iScience Interventional Corp Obtains $2,000,000 Series F Financing Round
Feed Type
Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=cd14e7de-098a-4bcb-bd79-e1806975a8ce&Preview=1
Date 4/21/2009
Company Name iScience Interventional Corp
Mailing Address 4055 Campbell Avenue Menlo Park, CA 94025
Company Description iScience Interventionalâ„¢ discovers and develops microcatheter and imaging technologies that enable ophthalmologists to deliver site-specific ocular therapies.
This new category of therapy is called Interventional Ophthalmology. It encompasses microcatheter-based therapies designed to access a wide range of anatomical structures within the eye to aspirate ocular fluids or deliver sterile ophthalmic solutions to the eye.
Proceeds Purposes The additional funding will enable iScience to build upon its unique position in the marketplace, continue commercial activities for glaucoma and develop further applications for treatments in the eye.
M&A Terms
Venture Investor L Capital Partners
Venture Investor Affinity Venture Group
Venture Investor Johnson & Johnson Development Corporation